Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

VIRACTA THERAPEUTICS, INC.

(VIRX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about VIRACTA THERAPEUTICS, INC.
11/30INSIDER SELL : Viracta Therapeutics
MT
11/29Viracta Therapeutics Secures FDA Orphan Drug Designation for Lymphoma Combo Therapy
MT
11/29Viracta Therapeutics Gets FDA Orphan Drug Designation for Nana-val
DJ
11/29Viracta Therapeutics Announces Orphan Drug Designation Granted by FDA for its All-Oral ..
PR
11/11Viracta Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corporat..
AQ
11/10Viracta Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Mont..
CI
11/10Viracta Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corporat..
PU
11/10SUNESIS : Q3 Earnings Snapshot
AQ
11/08Viracta Therapeutics Secures $50 Million Credit Facility from Silicon Valley Bank and O..
AQ
11/05Viracta Therapeutics Announces Upcoming Oral and Poster Presentations at the 2021 Ameri..
AQ
11/05Viracta Therapeutics Secures $50 Million Credit Facility from Silicon Valley Bank and O..
PU
11/05Viracta Therapeutics, Inc. Secures $50 Million Credit Facility from Silicon Valley Bank..
CI
10/06VIRACTA THERAPEUTICS : Multinational trial expands Viracta's clinical-stage pipeline beyon..
PU
10/06Viracta Therapeutics Initiates Phase 1b/2 Trial in Epstein-Barr Virus-Positive (EBV+) S..
CI
09/20VIRACTA THERAPEUTICS, INC.(NASDAQGS : VIRX) added to S&P Global BMI Index
CI
More most relevant news
All news about VIRACTA THERAPEUTICS, INC.
11/30INSIDER SELL : Viracta Therapeutics
MT
11/29Viracta Therapeutics Secures FDA Orphan Drug Designation for Lymphoma Combo Therapy
MT
11/29Viracta Therapeutics Gets FDA Orphan Drug Designation for Nana-val
DJ
11/29Viracta Therapeutics Announces Orphan Drug Designation Granted by FDA for its All-Oral ..
PR
11/11Viracta Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corporat..
AQ
11/10VIRACTA THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition..
AQ
11/10Viracta Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Mont..
CI
11/10Viracta Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corporat..
PU
11/10SUNESIS : Q3 Earnings Snapshot
AQ
11/08Viracta Therapeutics Secures $50 Million Credit Facility from Silicon Valley Bank and O..
AQ
More news
News in other languages on VIRACTA THERAPEUTICS, INC.
11/29Viracta Therapeutics obtient de la FDA la désignation de médicament orphelin pour une t..
08/23Viracta Therapeutics récupère les droits exclusifs d'une combinaison thérapeutique pour..
07/21Viracta déclare que la FDA a donné son feu vert à un essai de phase 1b/2 dans les tumeu..
06/01Viracta Therapeutics lance un essai de phase 2 pour évaluer la combinaison Nanatinostat..
06/01Viracta Therapeutics dépose un dossier de 200 millions de dollars sur un plateau mixte.
More news
Analyst Recommendations on VIRACTA THERAPEUTICS, INC.
05/03VIRACTA THERAPEUTICS : HC Wainwright Starts Viracta Therapeutics at Buy With $35 Price Tar..
MT
04/26VIRACTA THERAPEUTICS : SVB Leerink Initiates Viracta Therapeutics at Outperform With $18 P..
MT
03/25VIRACTA THERAPEUTICS : Evercore ISI Starts Viracta Therapeutics at Outperform with $45 Pri..
MT
More recommendations
Press releases
11/29Viracta Therapeutics Announces Orphan Drug Designation Granted by FDA for its All-Oral ..
PR
11/11Viracta Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corporat..
AQ
11/10VIRACTA THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition..
AQ
11/10Viracta Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corporat..
PU
11/10SUNESIS : Q3 Earnings Snapshot
AQ
More press releases
Upcoming event on VIRACTA THERAPEUTICS, INC.
12/11/21